Versuchen GOLD - Frei
How to contest unjustified claim rejections
Mint Hyderabad
|November 03, 2025
My husband was hospitalized from 14th to 22nd July 2024 for the treatment of chronic liver disease (CLD) at areputed hospital. After discharge, we submitted a reimbursement claim with all the required medical and policy documents.
However, the insurance company rejected the claim, stating that the insured had undergone varicose vein surgery nearly 15 years earlier, which they considered a preexisting disease (PED). The insurer concluded that the current ailment — chronic liver disease —was linked to this past surgery and, therefore, not eligible for coverage under the policy. Is this claim rejection medically and contractually justified? What are the next steps the policyholder should take to challenge this decision?
—Name withheld on request
Diese Geschichte stammt aus der November 03, 2025-Ausgabe von Mint Hyderabad.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Hyderabad
Mint Hyderabad
Make your own kind of music with this game
Winter is coming, so cosy up with these new game drops this month
1 min
November 05, 2025
Mint Hyderabad
When there's no will, there's no way home for your legacy
Wills ensure your assets are distributed as you wish; don't let the law decide your family’s fate
4 mins
November 05, 2025
Mint Hyderabad
The Centre's redefined strategy has put Naxalism on its last legs
The government's multipronged approach has led Naxals to lay down arms and reduced violence
3 mins
November 05, 2025
Mint Hyderabad
Japan's $132 bn borrowing binge alters global credit
The end of an era of essentially free money in Japan, a flurry of dealmaking and the AI boom have unleashed record overseas borrowing by the nation's firms whose renewed swagger is shaking up global markets.
2 mins
November 05, 2025
Mint Hyderabad
Venture debt players look to diversify with eye on growth
Gulf, Southeast Asia and Europe are the key targets amid limited opportunities in India
3 mins
November 05, 2025
Mint Hyderabad
IMFA to buy Tata's ferro chrome plant
Indian Metals and Ferro Alloys Ltd (IMFA) has signed definitive agreements to acquire Tata Steel's ferro chrome plant at Kalinganagar, Odisha, for a base consideration of ₹610 crore.
1 min
November 05, 2025
Mint Hyderabad
Serum’s new TB vaccine denied approval
India's top drug regulator has denied approval for Serum Institute of India Pvt. Ltd.'s new tuberculosis vaccine, calling the test data \"not adequate and conclusive\", according to a document and two government officials familiar with the matter.
2 mins
November 05, 2025
Mint Hyderabad
Incremental but still exceptional, with a big AI leap
The M5 chip brings real gains for those building or running AI models. For everyone else, the changes feel theoretical
3 mins
November 05, 2025
Mint Hyderabad
Govt to scrap renewables' contracts if found unviable
MNRE said any cancellations will be phased after all viable options are fully explored
1 mins
November 05, 2025
Mint Hyderabad
Brokers urge Sebi for Bank Nifty weekly options recall
Even as the Securities and Exchange Board of India (Sebi) weighs the fate of weekly index options for benchmarks such as Nifty and Sensex amid mounting retail investor losses, the country's largest brokers' forum has urged the regulator to restore weekly contracts on the Bank Nifty index.
1 mins
November 05, 2025
Listen
Translate
Change font size
